BlackRock
CARL

BlackRock’s Carlsmed CARL Stock Holding History

BlackRock’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.53M Buy
532,593
+85,701
+19% +$901K ﹤0.01% 3896
2026
Q1 		$4.04M Buy
446,892
+19,418
+5% +$235K ﹤0.01% 3912
2025
Q4 		$5.28M Buy
427,474
+42,035
+11% +$560K ﹤0.01% 3818
2025
Q3 		$5.16M Buy
+385,439
New +$5.27M ﹤0.01% 3771

Other funds holding CARL

JT
Jupiter Topco New York $245B AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
KC
KCM Capital Shawnee, Kansas $618M AUM
PC
Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PWM
Palumbo Wealth Management Great Neck, New York $478M AUM 50.95% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

BlackRock's CARL Position: Q2 2026 in Review

BlackRock increased its Carlsmed (CARL) stake by 19% in Q2 2026, buying an estimated $901K and bringing the position to 532,593 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #3896.

BlackRock first reported a position in CARL in Q3 2025 and has held it in 4 quarters since. 74 funds tracked by Wall St. Rank hold CARL as of Q2 2026.

  • BlackRock held 532,593 shares of Carlsmed worth $5.53M as of Q2 2026.
  • BlackRock bought 85,701 Carlsmed shares in Q2 2026, an estimated $901K.
  • Carlsmed made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #3896 holding.
  • BlackRock first reported a position in Carlsmed in Q3 2025 and has held it in 4 quarters since.
  • 74 funds tracked by Wall St. Rank held Carlsmed as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.